<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00576550</url>
  </required_header>
  <id_info>
    <org_study_id>SMR-1588</org_study_id>
    <nct_id>NCT00576550</nct_id>
  </id_info>
  <brief_title>A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema</brief_title>
  <official_title>A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ACO Hud Nordic AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Smerud Medical Research International AS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ACO Hud Nordic AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether a moisturizing cream can prevent hand
      eczema.Patients with previous hand eczema will be studied. In the second part of the study,
      it will be explored if a treatment regimen of a topical corticosteroid once daily is not
      inferior to treatment twice daily.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to relapse of hand eczema</measure>
    <time_frame>Up to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of patients showing clearance of hand eczema after betamethasone treatment once versus twice daily</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Hand Eczema</condition>
  <arm_group>
    <arm_group_label>1:1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Part 1 of the study (maintenance part)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1:2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Part 1 of the study (maintenance part)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2:1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Part 2 of the study (eczema part)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2:2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Part 2 of the study (eczema part)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Urea</intervention_name>
    <description>Urea cream applied twice daily up to six months</description>
    <arm_group_label>1:1</arm_group_label>
    <other_name>Canoderm 5% kräm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>betamethasone valerate</intervention_name>
    <description>Application once daily for two weeks</description>
    <arm_group_label>2:1</arm_group_label>
    <other_name>Betnoderm 0,1 % kräm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>betamethasone valerate</intervention_name>
    <description>Application twice daily for two weeks</description>
    <arm_group_label>2:2</arm_group_label>
    <other_name>Betnoderm 0,1 % kräm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically proven history of hand eczema

          -  At inclusion controlled state of hand eczema (≤3 on Hand Eczema Extent Score, HEES)

          -  Daily use of moisturising treatment

          -  Either gender

          -  Age 18 or above

          -  Written Informed Consent

        Exclusion Criteria:

          -  Possible allergy to ingredients in the study medications

          -  At study start active psoriatic lesions or active atopic eczema lesions on the hands.
             Active bacterial, fungal or viral infection of the hands

          -  Patients who are pregnant or breast-feeding, or who plan to become pregnant during the
             course of the study

          -  Use of any concomitant medication that may interfere with the study related activities
             or assessment of efficacy

          -  Any patient related factor suggesting potential poor compliance with study procedures
             (e.g. psychiatric disorders, history of alcohol or substance abuse)

          -  Any serious medical condition which, in the opinion of the investigator, may interfere
             with the evaluation of the results

          -  Inclusion in a study of an investigational drug within 60 days prior to start of
             treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gro Moerk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rikshospitalet, Oslo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medi 3 Innlandet</name>
      <address>
        <city>Hamar</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colosseumklinikken</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr Funks hudklinikk</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2007</study_first_submitted>
  <study_first_submitted_qc>December 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2007</study_first_posted>
  <last_update_submitted>October 10, 2008</last_update_submitted>
  <last_update_submitted_qc>October 10, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2008</last_update_posted>
  <responsible_party>
    <name_title>Karin Wirén</name_title>
    <organization>ACO HUD NORDIC</organization>
  </responsible_party>
  <keyword>Hand eczema</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

